logo

For the Inventor, By the Inventor

Fort Collins, CO, United States of America

Gary L Stiegler

This inventor holds 18 USPTO granted patents, primarily in Flea Protease Research. Top assignee: Heska Corporation. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary L Stiegler. Retrieved from https://idiyas.com/inventor/gary-l-stiegler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:

goldMedal18 out of 177 
 
Heska Corporation
 patents

Years Active: 1998-2002

Loading Chart...
Areas of Expertise:
Flea Protease Proteins
Nucleic Acid Molecules
Ectoparasite Biology
Serine Protease
Leucine Aminopeptidase
Antibody Response
Histamine Releasing Factor
Amino Acid Sequences
18 patents (USPTO):Explore Patents
1. 6406900 - Flea protease proteins, nucleic acid molecules and uses thereof (2002-06-18),
2. 6232096 - Flea serine protease nucleic acid molecules and uses thereof (2001-05-15),
3. 6214579 - Flea leucine aminopeptidase nucleic acid molecules and uses thereof (2001-04-10),
4. 6210920 - Flea protease proteins, nucleic acid molecules, and uses thereof (2001-04-03),
5. 6204010 - Flea protease proteins, nucleic acid molecules, and uses thereof (2001-03-20),
6. 6180383 - Flea leucine aminopeptidase proteins and uses thereof (2001-01-30),
7. 6177258 - Flea protease proteins and uses thereof (2001-01-23),
8. 6156556 - Flea protease proteins, nucleic acid molecules, and uses thereof (2000-12-05),
9. 6150125 - Flea protease proteins and uses thereof (2000-11-21),
10. 6146870 - Flea protease proteins (2000-11-14),
11. 6139840 - Methods of eliciting an antibody response using flea protease proteins (2000-10-31),
12. 6121035 - Flea aminopeptidase proteins and uses thereof (2000-09-19),
13. 6077687 - Flea aminopeptidase nucleic acid molecules and uses thereof (2000-06-20),
14. 6063902 - Ectoparasite histamine releasing factor, genes and uses thereof (2000-05-16),
15. 5972645 - Flea serine protease nucleic acid molecules (1999-10-26),

Title: Gary L Stiegler: Innovator in Flea Protease Proteins

Introduction

Gary L Stiegler is a prominent inventor based in Ft. Collins, CO (US). He has made significant contributions to the field of protease proteins, particularly in relation to flea infestations. With a total of 18 patents to his name, Stiegler's work has had a considerable impact on veterinary medicine.

Latest Patents

Stiegler's latest patents focus on flea protease proteins and nucleic acid molecules. One of his inventions relates to flea serine protease proteins and flea cysteine protease proteins. This invention includes methods to obtain these proteins, nucleic acid molecules, antibodies, and inhibitors. Additionally, it encompasses therapeutic compositions that can protect host animals from flea infestations. Another patent addresses flea serine protease proteins, aminopeptidase proteins, and their respective nucleic acid molecules. This invention also includes methods for obtaining these proteins and therapeutic compositions for flea protection.

Career Highlights

Gary L Stiegler is associated with Heska Corporation, where he continues to innovate in the field of veterinary medicine. His extensive research and development efforts have led to advancements in treatments for flea infestations, benefiting both pets and their owners.

Collaborations

Stiegler has collaborated with notable coworkers such as Shirley Wu Hunter and Robert B Grieve. Their combined expertise has contributed to the success of his inventions and the development of effective therapeutic solutions.

Conclusion

Gary L Stiegler's work in the field of flea protease proteins has led to significant advancements in veterinary medicine. His innovative patents and collaborations highlight his commitment to improving animal health and welfare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…